💊 Arzneimittel A-Z 🧬 Targets 🛠 Werkzeuge 📚 Leitfäden
Alle Arzneimittel Arzneimittelklassen Therapeutische Bereiche Nebenwirkungen
Leitfäden Glossar Zeitleiste
Vergleiche Arzneimittelreisen Arzneimittel-Wirkstoffgruppen
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Naproxen Sodium

CHEMBL1200806 Phase 4 Zugelassen Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
252.2 g/mol
LogP
—
Phase
4

This is the sodium salt form of naproxen that is absorbed more quickly, providing faster pain relief for the same conditions.

Molekularmasse

252,2400 g/mol

TPSA

49,40 Ų

Therapeutische Bereiche

Endometriosis Cardiovascular Disease Hematology Pain Management Rheumatoid Arthritis Migraine Generalized Anxiety Disorder Multiple Sclerosis Non-Alcoholic Fatty Liver Disease Hypertension Breast Cancer Gout Chronic Pain Tuberculosis Prostate Cancer Colorectal Cancer

Wirkmechanismus

Non-selective COX inhibitor.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Non-selective COX inhibitor.

2D-Struktur

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+]

                

                

                
                

                    
InChI

                    
InChI=1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1

                

                

                

                    
                    

                        
Molecular Formula

                        
C14H13NaO3

                    

                    
                    

                        
HBD / HBA

                        
- / 3

                    

                    
                    

                        
Rotierbare Bindungen

                        
3

                    

                    
                    
                    

                        
Schwere Atome

                        
18

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
Häufig gestellte Fragen

                

                    
                    

                        
                        

                            
This is the sodium salt form of naproxen that is absorbed more quickly, providing faster pain relief for the same conditions.

                        

                    

                    

                    

                    
                    

                        
                        

                            
Non-selective COX inhibitor.

                        

                    

                    

                    

                    

                        
                        

                            
Yes, Naproxen Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL1200806.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 23681059.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.




        


        
        
    


    



    
Medizinischer Haftungsausschluss

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.